BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23022698)

  • 1. Association between anthropometric parameters and measurements of liver stiffness by transient elastography.
    Wong GL; Chan HL; Choi PC; Chan AW; Lo AO; Chim AM; Wong VW
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):295-302.e1-3. PubMed ID: 23022698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years.
    Roulot D; Costes JL; Buyck JF; Warzocha U; Gambier N; Czernichow S; Le Clesiau H; Beaugrand M
    Gut; 2011 Jul; 60(7):977-84. PubMed ID: 21068129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndrome.
    Mikolasevic I; Milic S; Orlic L; Stimac D; Franjic N; Targher G
    J Diabetes Complications; 2016; 30(7):1347-53. PubMed ID: 27324703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index.
    Petta S; Di Marco V; Cammà C; Butera G; Cabibi D; Craxì A
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1350-60. PubMed ID: 21517924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outreach screening of drug users for cirrhosis with transient elastography.
    Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
    Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country.
    Das K; Sarkar R; Ahmed SM; Mridha AR; Mukherjee PS; Das K; Dhali GK; Santra A; Chowdhury A
    Hepatology; 2012 Feb; 55(2):584-93. PubMed ID: 21952989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study.
    Conti F; Vukotic R; Foschi FG; Domenicali M; Giacomoni P; Savini S; Lanzi A; Dall'Aglio AC; Saini G; Matroroberto M; Bernardi M; Stefanini GF; Andreone P
    Dig Liver Dis; 2016 Nov; 48(11):1357-1363. PubMed ID: 27522549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients.
    Myers RP; Pomier-Layrargues G; Kirsch R; Pollett A; Duarte-Rojo A; Wong D; Beaton M; Levstik M; Crotty P; Elkashab M
    Hepatology; 2012 Jan; 55(1):199-208. PubMed ID: 21898479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.
    Cassinotto C; Boursier J; de Lédinghen V; Lebigot J; Lapuyade B; Cales P; Hiriart JB; Michalak S; Bail BL; Cartier V; Mouries A; Oberti F; Fouchard-Hubert I; Vergniol J; Aubé C
    Hepatology; 2016 Jun; 63(6):1817-27. PubMed ID: 26659452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-obese patients with nonalcoholic fatty liver disease may use a lower liver stiffness cut-off to assess fibrosis stages.
    Shi YW; Wang QY; Zhao XY; Sun YM; Kong YY; Ou XJ; Jia JD; Wu SS; You H
    J Dig Dis; 2020 May; 21(5):279-286. PubMed ID: 32336033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
    Myers RP; Pomier-Layrargues G; Kirsch R; Pollett A; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    J Hepatol; 2012 Mar; 56(3):564-70. PubMed ID: 22027584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis.
    Chan WK; Treeprasertsuk S; Goh GB; Fan JG; Song MJ; Charatcharoenwitthaya P; Duseja A; Dan YY; Imajo K; Nakajima A; Ho KY; Goh KL; Wong VW
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2570-2580.e37. PubMed ID: 30876959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?
    Pongpit J; Porntharukchareon S; Kaewduang P; Promson K; Stitchantrakul W; Petraksa S; Thakkinstian A; Kositchaiwat C; Rajatanavin N; Sobhonslidsuk A
    Biomed Res Int; 2016; 2016():7963972. PubMed ID: 27006950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Inflammation May Influence Liver Stiffness Measurements by Transient Elastography in Children and Young Adults.
    Raizner A; Shillingford N; Mitchell PD; Harney S; Raza R; Serino J; Jonas MM; Lee CK
    J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):512-517. PubMed ID: 27540711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation.
    Kumar R; Rastogi A; Sharma MK; Bhatia V; Tyagi P; Sharma P; Garg H; Chandan Kumar KN; Bihari C; Sarin SK
    Dig Dis Sci; 2013 Jan; 58(1):265-74. PubMed ID: 22790906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.